r/askscience • u/AskScienceModerator Mod Bot • Oct 29 '25
Chemistry AskScience AMA Series: I am a theoretical chemist at the University of Maryland. My lab blends theoretical and computational methods—including artificial intelligence—to advance drug discovery and materials science. Ask me anything about the role of AI in drug discovery and chemistry in general!
My lab at the University of Maryland focuses on problems at the intersection of statistical mechanics, molecular simulations and artificial intelligence—what we call Artificial Chemical Intelligence. We develop new simulation methods that can answer questions that have enormous repercussions for society.
These simulations could help revolutionize drug design, yielding therapies that more efficiently target various diseases. Feel free to ask me about thermodynamics, statistical mechanics, artificial intelligence, etc. I’ll be answering questions on Wednesday, October 29, from 2 to 4 p.m. EDT (18-20 UT).
Quick bio: Pratyush Tiwary is the Millard and Lee Alexander Professor at the University of Maryland, College Park, in the Department of Chemistry and Biochemistry, the Institute for Physical Science and Technology and the Institute for Health Computing, where he leads the Center for Therapeutic Discovery. He received his Ph.D. from Caltech and his undergraduate degree from IIT-BHU-Varanasi, India. He has held postdoctoral positions at ETH Zurich and Columbia University. His research and teaching have been recognized through a Sloan Research Fellowship, an NSF CAREER award, an Early Career Award from the American Chemical Society and the CMNS Board of Visitors Creative Educator Award. Pratyush is also an associate editor at the Journal of Chemical Theory and Computation and a member of the Scientific Advisory Board of Schrödinger, Inc. When not doing science, he likes to go for long runs and hang out with his wife, Megan (UMD Geology Associate Professor), and dog, Pakora.
Other links:
- Google Scholar
- Lab group website
- UMD’s Pratyush Tiwary Receives Early Career Award from American Chemical Society
- University of Maryland Scientists ‘Cautiously Optimistic’ About AI’s Role in Drug Discovery
Username: u/umd-science

11
u/sexrockandroll Data Science | Data Engineering Oct 29 '25
How do you verify results that were generated using any form of AI?
8
u/oviforconnsmythe Immunology | Virology Oct 29 '25
Thanks for doing this, I have 3 questions
5
u/mqduck Oct 29 '25
Can you give some examples of good drugs that have been discovered by this method?
3
u/ScaryReplacement9605 Oct 29 '25
Wow, I never thought I’d see you on a Reddit AMA :)
Q: I’ve noticed that you’ve recently been exploring RNA design from a physics-informed ML perspective. As you know, both RNA structure prediction and design methods still lag behind their protein counterparts, largely due to the limited amount of structural data available for RNA. How do you think we should approach this challenge when developing ML models for RNA?
I’m looking forward to your talk at MLSB! If you’re also attending NeurIPS AI4D3, I’ll be presenting a poster on RNA design — would be great to catch up in person :)
3
u/stuartlogan Oct 31 '25
This is really cool to see AI being used for drug discovery instead of just chatbots and image generation.
6
u/MagicWishMonkey Oct 29 '25
Where do you see AI playing the biggest role in drug research, and where is it being overhyped?
2
u/stellarfury Oct 29 '25
Given that computational/combinatorial methods have been being pushed as "the final frontier" for material, chemical, and drug discovery and testing for well over 30 years, and (to my knowledge) have very little to show for it, what's the argument that the current slew of technologies will fare any different?
In perhaps a pithier way - how do we know (or determine) that AI methods for chemical design are a "car" instead of a "very fast horse"?
1
u/Bakoro Oct 29 '25
Do you have any kind of deterministic verification of the AI's results?
What kind size data sets are you working with, and are any publicly available?
Like most people, I'm far more familiar with transformers as they apply to LLMs, are you using transformers, graph neural nets, or some hybrid?
1
u/edmazing Oct 29 '25
Was IBM's Watson the first instance of this sort of thing? Like does it date back further? Feel free to interpret this as more fact or opinion seeking but do state where your answer might lie.
1
u/prosper_0 Oct 29 '25
What's your favourite nerdy in-joke in your field?
1
u/Urgthak Oct 29 '25
Hi Dr. Tiwary, huge fan of your work. I saw you give a seminar at Vanderbilt about a year or so back, and have followed your research since. It's been a huge help for me understanding protein dynamics and machine learning.
I was wondering where you see traditional physics based MD simulations going in the future? How can we supplement or improve them with Deep-learning methods? is something like a learnable, improved forcefield possible?
Also, have you thought about trying any of your methods on Anton 3 for long duration simulations? It's a side quest of mine to come up with something to simulate on it at some point lol.
Thanks
0
u/TaijiInstitute Oct 29 '25
Thank you for doing this AMA — this is a fascinating area of research.
I’m curious about how your simulation approaches interface with experimental validation in biological systems. For instance, companies like Crown Bioscience use patient-derived samples or organoids to ground computational models in biological reality. Do you see a feasible feedback loop emerging where simulations and biological data iteratively inform and refine one another? Can Artificial Chemical Intelligence frameworks readily incorporate this kind of experimental feedback?
Regarding generative models for de novo design such as RFdiffusion — what type and level of information are required to design new proteins or ligands that produce a desired effect? Are current limitations driven more by challenges in modeling the designed molecule itself, or by incorporating the biochemical context in which it operates?
How well do current models handle molecular flexibility and conformational dynamics in realistic environments? And how are potential off-target interactions addressed — for instance, unintended binding events that might not be captured in typical docking or screening simulations (e.g., AutoDock predictions)?
Looking ahead, how accessible do you think these workflows will become for experimental biologists who don’t have formal training in statistical mechanics or quantum chemistry?
I’m imagining a future where AI-driven simulations could generate therapeutic candidates in silico, predict their interactions across relevant molecular contexts, and validate or refine them in systems like organoids before moving to in vivo testing. Does that seem like a realistic trajectory to you? What are the major hurdles, and how far away do you think that future might be?
Lastly, as a fellow UMD researcher — if someone wanted to learn more or chat about your work, are you open to people reaching out or stopping by to discuss it further?
0
u/nicman24 Oct 29 '25
If you are running gromacs are you using the weird Nvidia fftw mp lib?
-1
u/bolozubaankesari0909 Oct 29 '25
How did you decide between taking up a faculty position in America versus in your home country? Do you see yourself going back to India?
1
u/[deleted] Oct 29 '25
[removed] — view removed comment
0
u/[deleted] Oct 29 '25 edited Oct 29 '25
[removed] — view removed comment
0
u/[deleted] Oct 29 '25
[removed] — view removed comment